袁玉国
  • 学位:博士
  • 职称:副高级
  • 所在单位:兽医学院

博士生导师

硕士生导师

教师英文名称:Yuguo Yuan
教师拼音名称:Yuan Yuguo
电子邮箱:
入职时间:2010-06-01
学历:博士研究生毕业
办公地点:扬州大学文汇路校区45楼102室
性别:
联系方式:0514-87979228
在职信息:在岗
毕业院校:扬州大学

学科:临床兽医学

当前位置: 中文主页 >> 科学研究 >> 论文成果
MicroRNA-7641 is a regulator of ribosomal proteins and a promising targeting factor to improve the efficacy of cancer therapy
点击次数:
影响因子:
5.1
发表刊物:
Sci Rep
摘要:
Many diseases, including myocardial infarction, autoimmune disease, viral diseases, neurodegenerative diseases, and cancers, are frequently diagnosed with aberrant expression of microRNAs (miRNAs) and their allied pathways. This indicates the crucial role of miRNAs in maintaining biological and physiological processes. miR-7641 is a miRNA whose role in disease has not been fully investigated. In the present study, we investigated the expression pattern of miR-7641 and its target genes in different cancer cells, as well as in clinical cancer patients. Our data confirmed RPS16 and TNFSF10 as two direct targets of miR-7641, while gene expression study showed that a group of genes are also deregulated by miR-7641, including many ribosomal proteins that are frequently co-expressed with RPS16 in breast cancer. Direct inhibition of miR-7641 using a locked nucleic acid upregulated the expression of its target genes, sensitized cancer cells, and enhanced the efficiency of therapeutic agents such as doxorubicin. In addition, inhibition of miR-7641 boosted doxorubicin-mediated apoptosis of cancer cells via upregulation of apoptotic molecules Caspase 9 (CAS9) and poly ADP ribose polymerase (PARP) and downregulation of anti-apoptotic molecule BCL2. Thus, miR-7641 might be a clinically important cancer biomarker. Inhibition of miR-7641 expression could be an efficient treatment strategy for clinical patients.
合写作者:
Yu-Guo Yuan
论文类型:
SCI、
文献类型:
Article
卷号:
7
期号:
1
是否译文:
发表时间:
2017-08-21
收录刊物:
SCI
个人简介

袁玉国,博士,副教授,硕士、博士生导师。2010年毕业于扬州大学兽医学院,获临床兽医学博士学位,并留校任教。2015.10—2017.7韩国Konkuk University博士后,2017.9—2018.9韩国Gyeongsang National University访问学者。

长期从事动物体细胞克隆和转基因克隆的研究工作,2007在国内外首次报道利用成年乳腺上皮细胞获得克隆山羊,先后获得转人乳铁蛋白,白蛋白等转基因克隆羊。利用TALENCas9技术获得Fel d1基因敲除猫、MSTN基因敲除山羊,人高血脂兔动物模型(兔)等。同时开展了功能纳米材料的制备及其在抗菌、抗肿瘤和化妆品上的应用。先后主持了国家自然科学基金、国家转基因重大专项子课题、江苏省种业“揭榜挂帅”等15余项课题的研究工作,在 EBioMedicineInt J NanomedicineCellsOxid Med Cell Longev,  Int J Mol Sci,Mol Reprod DevTheriogenology等杂志发表SCI论文30余篇,获得省部级等科技奖励2项、发明专利1项。


其他联系方式

邮编 :

  • 传真 :

  • 通讯/办公地址 :

  • 办公室电话 :

  • 邮箱 :

  • 扫一扫用手机查看